Report No. 20/2026 Execution of a Funding Agreement with the National Centre for Research and Development for the Project “Innovative Cell-Free Biological Medicinal Product for Veterinary Applications (InnoBioVet)” under the European Funds for a Modern Economy Programme

_MACHINE TRANSLATION_ Execution of a Funding Agreement with the National Centre for Research and Development for the Project “Innovative Cell-Free Biological Medicinal Product for Veterinary Applications (InnoBioVet)” under the European Funds for a Modern Economy Programme The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer” or the “Company”), with reference […]

Report No. 19/2026 Appointment of a Member of the Supervisory Board

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wrocław (the “Issuer”, the “Company”), hereby announces that the Ordinary General Meeting of the Company held today, i.e., on 23 June 2026, by virtue of Resolution No. 18/06/2026 on the appointment of a Member of the Supervisory Board, appointed Mr. Szymon Ruta […]

Report No. 18/2026 Content of the resolutions adopted during the Ordinary General Meeting held on 23 June 2026, together with information on the announcement of a break in the proceedings until 7 July 2026 at 13:30

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wrocław (the “Issuer”, the “Company”), hereby provides, as an attachment to this current report, the content of the resolutions adopted by the Ordinary General Meeting (the “OGM”) held on 23 June 2026, together with the voting results. During the OGM, no items […]